The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Dementia care costs and outcomes: a systematic review
Open accessAbstract
OBJECTIVE: We reviewed evidence on the cost-effectiveness of prevention, care and treatment strategies in relation to dementia. METHODS: We performed a systematic review of available literature on economic evaluations of dementia care, searching key databases and websites in medicine, social care and economics. Literature reviews were privileged, and other study designs were included only to fill gaps in the evidence base. Narrative analysis was used to synthesise the results. RESULTS: We identified 56 literature reviews and 29 single studies offering economic evidence on dementia care. There is more cost-effectiveness evidence on pharmacological therapies than other interventions. Acetylcholinesterase inhibitors for mild-to-moderate disease and memantine for moderate-to-severe disease were found to be cost-effective. Regarding non-pharmacological treatments, cognitive stimulation therapy, tailored activity programme and occupational therapy were found to be more cost-effective than usual care. There was some evidence to suggest that respite care in day settings and psychosocial interventions for carers could be cost-effective. Coordinated care management and personal budgets held by carers have also demonstrated cost-effectiveness in some studies. CONCLUSION: Five barriers to achieving better value for money in dementia care were identified: the scarcity and low methodological quality of available studies, the difficulty of generalising from available evidence, the narrowness of cost measures, a reluctance to implement evidence and the poor coordination of health and social care provision and financing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although UK policy recognises that psychological therapy for carers of family members with dementia should be a key component of high quality dementia care, in practice resources are not available, and this is partly because so far effective therapies have been delivered only by highly trained clinical psychologists and evidence on cost effectiveness is lacking.7”
From Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial (2013) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“A recent review found some evidence that such interventions could lead to greater improvements in outcome and also generate cost savings.20”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease
Mittelman, M. S., Haley, W. E., Clay, O. J., & Roth, D. L. (2006) · Neurology · doi:10.1212/01.wnl.0000242727.81172.91 · Cited by 602
Wu, O., Robertson, L., Twaddle, S., Lowe, G. D. O., Clark, P., Greaves, M., Walker, I. D., Langhorne, P., Brenkel, I., Regan, L., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10110 · Cited by 489
Bond, M., Rogers, G., Peters, J., Anderson, R., Hoyle, M., Miners, A. H., Moxham, T., Davis, S., Thokala, P., Wailoo, A., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16210 · Cited by 308
Graff, M. J. L., Adang, E., Vernooij-Dassen, M. J. M., Dekker, J., Jönsson, L., Thijssen, M., Hoefnagels, W. H. L., & Rikkert, M. G. M. O. (2008) · BMJ · doi:10.1136/bmj.39408.481898.be · Cited by 270
Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis
Knapp, M. R. J., Thorgrimsen, L., Patel, A. K., Spector, A. E., Hallam, A., Woods, B. T., & Orrell, M. W. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.010561 · Cited by 240
Self-citationLoveman, E., Green, C., Kirby, J., Takeda, A., Picot, J., Payne, L., & Clegg, A. P. (2006) · Health Technology Assessment · doi:10.3310/hta10010 · Cited by 220
Physical activity programs for persons with dementia
Forbes, D., Forbes, S., Morgan, D. G., Markle-Reid, M., Wood, J., & Culum, I. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006489.pub2 · Cited by 194
Comas‐Herrera, A., Wittenberg, R., Pickard, L., & Knapp, M. R. J. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1830 · Cited by 174
Self-citationRespite care for people with dementia and their carers
Maayan, N., Soares‐Weiser, K., & Lee, H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004396.pub3 · Cited by 172
Flagged first, then by citations
Research works printed but not linked: 8
- Hulstaert F, 2009, Pharmaceutical and Non‐pharmaceutical Interventions for Alzheimer's Disease, a Rapid Assessment
- National Audit Office, 2007, Improving Services and Support for People with Dementia
- National Institute for Health and Clinical Excellence, 2006, Donepezil, Galantamine, Rivastigmine (Review) and Memantine for the Treatment of Alzheimer's Disease
- National Institute for Health and Clinical Excellence, 2009, Donepezil, Galantamine, Rivastigmine (Review) and Memantine for the Treatment of Alzheimer's Disease (Amended)
- National Institute for Health and Clinical Excellence.2011.Donepezil Galantamine Rivastigmine (Review) and memantine for the Treatment of Alzheimer's Disease.Review of NICE Technology Appraisal Guidance 111. National Institute for Health and Clinical Excellence (NICE): London.
- NICE‐SCIE, 2006, Clinical Guideline
- NICE‐SCIE, 2011, Clinical Guideline
- SBU.2008.Dementia—Caring Ethics Ethnical and Economical Aspects.A Systematic Review volume 3. The Swedish Council on Technology Assessment in Health Care: Stockholm Sweden.
Cited by
Sorted by citations
UK health performance: findings of the Global Burden of Disease Study 2010
Murray, C. J., Richards, M. A., Newton, J. N., Fenton, K. A., Anderson, H. R., Atkinson, C., Bennett, D., Bernabé, E., Blencowe, H., Bourne, R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60355-4 · Cited by 553
Dementia: timely diagnosis and early intervention
Robinson, L., Tang, E., & Taylor, J.-P. (2015) · BMJ · doi:10.1136/bmj.h3029 · Cited by 503
Ballard, C., Corbett, A., Orrell, M., Williams, G., Moniz-Cook, E., Romeo, R., Woods, B., Garrod, L., Testad, I., Woodward-Carlton, B., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002500 · Cited by 263
Self-citationLivingston, G., Barber, J., Rapaport, P., Knapp, M., Griffin, M., King, D., Livingston, D., Mummery, C., Walker, Z., Hoe, J., et al. (2013) · BMJ · doi:10.1136/bmj.f6276 · Cited by 233
Self-citationAgis-Torres, A., Sollhuber, M., Fernandez, M., & Sanchez-Montero, J. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x113116660047 · Cited by 202
Metadata
- Authors
- Knapp, M., Iemmi, V., & Romeo, R.
- Affiliations
- King's College London (GB)
- Centre for the Economics of Mental Health Institute of Psychiatry at King's College London London UK
- Corresponding author
- Knapp, Martin
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2012-08-12
- Volume
- 28
- Issue
- 6
- Pages
- 551-561
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W1940929028
- Cited by
- 126
- References
- 46
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 5 · 2022: 11 · 2021: 6 · 2020: 7 · 2019: 11 · 2018: 16 · 2017: 10 · 2016: 16 · 2015: 15 · 2014: 13 · 2013: 9
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Geriatric Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
- London School of Economics and Political Science Theses Online (London School of Economics and Political Science) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Alzheimer's Society
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
- Keywords
- dementia care, cost-effectiveness, economic evaluation, acetylcholinesterase inhibitors, memantine, cognitive stimulation therapy, occupational therapy, respite care, personal budgets, implementation barriers, health and social care coordination
- MeSH terms
- Cost-Benefit Analysis, Delivery of Health Care, Dementia, Humans, Preventive Health Services, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
